Francesca Conti

Medicine & Life Sciences

1. SARS Virus 100%
2. Ataxia Telangiectasia 86%
3. Immunity 76%
4. Severe combined immunodeficiency due to adenosine deaminase deficiency 71%
5. Bruton type agammaglobulinemia 68%
6. Sorafenib 55%
7. seletalisib 53%
8. Allergy and Immunology 50%
9. Infections 50%
10. Activated PI3K-delta Syndrome 49%
11. Hematopoietic Stem Cells 44%
12. Phosphatidylinositol 3-Kinases 44%
13. Schimke immunoosseous dysplasia 43%
14. T-Lymphocytes 43%
15. Phenotype 42%
16. B-Lymphocytes 42%
17. Bacterial Infections 42%
18. Mutation 41%
19. Inflammation 41%
20. Macrophages 39%
21. Cakut 37%
22. Hepatocellular Carcinoma 36%
23. Mortality 36%
24. Macrophage Activation Syndrome 36%
25. Survival 35%
26. Necrotizing Pneumonia 35%
27. Transition to Adult Care 35%
28. Mycoses 34%
29. DiGeorge Syndrome 33%
30. Histiocytosis 32%
31. Lymphopenia 32%
32. Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 32%
33. Chronic Granulomatous Disease 30%
34. Hemophagocytic Lymphohistiocytosis 29%
35. Morbidity 28%
36. Antiphospholipid Antibodies 28%
37. Multicenter Studies 28%
38. Human Herpesvirus 4 28%
39. Natural Killer Cells 27%
40. Epstein-Barr Virus Infections 27%
41. Antiphospholipid Syndrome 27%
42. Nutrition Assessment 27%
43. MYD88 Deficiency 26%
44. Viremia 25%
45. Ribonucleases 25%
46. Registries 25%
47. Rheumatology 24%
48. Autoimmunity 24%
49. Down Syndrome 23%
50. Pregnancy Outcome 22%